A 6-month, randomized, double-blind, placebo-controlled pilot discontinuation trial following response to haloperidol treatment of psychosis and agitation in Alzheimer's disease.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples